Abstract. African elephants of reproductive age in zoos are experiencing high rates of ovarian cycle problems (.40%) and low reproductive success. Previously, our laboratory found that 1/3 of acyclic females exhibit hyperprolactinaemia, a likely cause of ovarian dysfunction. This follow-up study re-examined hyperprolactinaemia in African elephants and found the problem has increased significantly to 71% of acyclic females. Circulating serum progestagens and prolactin were analysed in 31 normal cycling, 13 irregular cycling and 31 acyclic elephants for 12 months. In acyclic females, overall mean prolactin concentrations differed from cycling females (P , 0.05), with concentrations being either higher (n ¼ 22; 54.90 AE 13.31 ng mL À1 ) or lower (n ¼ 9; 6.47 AE 1.73 ng mL À1 ) than normal. No temporal patterns of prolactin secretion were evident in elephants that lacked progestagen cycles. In cycling females, prolactin was secreted in a cyclical manner, with higher concentrations observed during nonluteal (34.38 AE 1.77 and 32.75 AE 2.61 ng mL
Introduction
At present, 41.1% of post-pubertal female African elephants in North America experience oestrous cycle abnormalities, such as irregular or no ovarian activity (Dow et al. 2011) . Individuals that do not cycle exhibit baseline concentrations of progestagens and are considered infertile (Brown and Lehnhardt 1997; Brown 2000) . One significant endocrine finding associated with abnormal ovarian activity is high circulating prolactin concentrations; i.e. hyperprolactinaemia (Brown et al. 2004a; Meyer et al. 2004) . In 2004, we completed a comprehensive study to determine if specific hormonal imbalances were causative factors to ovarian acyclicity (Brown et al. 2004a) . Of the 10 hormones examined (luteinising hormone, follicle stimulating hormone, prolactin, thyroid stimulating hormone (TSH), oestradiol, free and total triiodide thyronine (T 3 ), free and total thyroxin (T 4 ) and cortisol), only prolactin differed and was significantly elevated in one-third (11/33) of acyclic females.
Prolactin is a single-chain peptide hormone involved in a variety of biological processes, most notably mammary gland development and lactation (Li et al. 1987 (Li et al. , 1989 Rillema 1994 Rillema , 1998 . Secreted by the anterior pituitary gland, prolactin is under constant inhibitory control by dopamine released from tuberoinfundiular dopamine (TIDA) neurons in the arcuate nucleus of the hypothalamus (Ben-Jonathan, 1994 ). This hormone participates in a variety of physiological processes important to reproduction (Freeman et al. 2000) . It is the main luteotropic hormone during gestation, supporting luteal progesterone secretion by decreasing the progesterone metabolising enzyme 20a-hydroxysteroid dehydrogenase (Lamprecht et al. 1969; Bast and Melampy 1972; Morishige and Rothchild 1974) , and is anti-atretic at the preovulatory follicle level by decreasing intracellular calcium concentrations (Lebedeva et al. 1998) . In African (Bechert et al. 1999; Yamamoto et al. 2010) but not Asian (Brown et al. 2004a ) elephants, prolactin increases in a cyclic pattern during the nonluteal phase of the oestrous cycle, and is presumed to be important for facilitating follicle selection and development similar to that described in other species (Yoshimura et al. 1989 (Yoshimura et al. , 1991 Larsen et al. 1990; Li et al. 2011) .
Except for high levels of prolactin during pregnancy and lactation, hyperprolactinaemia is a pathological condition at any age and a primary cause of amenorrhea and anovulation in several species (Yu et al. 1981; Jones 1989; Bachelot and Binart 2007) . In general, the negative effects of chronic elevated prolactin secretion on reproductive function involve inhibition of hypothalamic gonadotrophin-releasing hormone (GnRH) release and subsequent suppression of pituitary LH and FSH secretion, resulting in anovulation (Bachelot and Binart 2007) . Temporary hyperprolactin secretion has been linked to sleep apnoea, anorexia, protein ingestion, hypoglycaemia, stress, chest wall stimulation and trauma (Woolf 1986; Jones 1989; Billings et al. 2002) . However, longer-term hyperprolactinaemia-induced infertility is generally associated with pituitary prolactinomas (Mah and Webster 2002) . Any physiological or pharmacological process that disrupts dopamine secretion or interferes with the delivery of dopamine to the portal vessels can cause hyperprolactinaemia (Bachelot and Binart 2007) . The aetiology of hyperprolactinaemia in elephants has yet to be established, but preliminary data showing that a dopamine agonist (cabergoline) and antagonist (domperidone) affect prolactin secretion (Ball and Brown 2006; J. Brown, unpubl. data) suggest that it is under dopamine control similar to other species.
The main objective of this study was to compare prolactin secretory patterns between cycling and noncycling female African elephants and to determine if the percentage of acyclic females experiencing hyperprolactinaemia had changed since the last endocrine study published in 2004 (Brown et al. 2004a) . We also assessed prolactin secretion in irregular cycling females, as it is now clear that several elephants do not clearly fall into cycling or noncycling categories. The eventual goal is to better understand the role of prolactin in normal and abnormal ovarian function, and to develop management or pharmaceutical strategies to mitigate cyclicity problems in captive African elephants.
Materials and methods

Animals and sample collections
Weekly serum samples from cyclic (n ¼ 31), irregular cycling (n ¼ 13) and acyclic (n ¼ 31) postpubertal female African elephants were collected from an ear vein or saphenous vein in a rear leg for 12 months for progestagen and prolactin analyses. Females that exhibited sustained progestagen concentrations of ,0.1 ng mL À1 for at least a 1-year period before this study were considered to be acyclic. Normal cycling females were those that experienced consistent oestrous cycles consisting of 4-6-week nonluteal and 8-10-week luteal phases (Brown 2000) . As previously characterised by Brown et al. (2004b) , irregular cycling females were those that exhibited extended nonluteal phases (.9 weeks) or shortened luteal phases (,6 weeks), with or without the presence of marked, inconsistent serum progestagen concentrations during nonluteal or luteal phases as compared with those of normal cycling females. As defined by Prado-Oviedo (2011) , elephants with prolactin concentrations $30 ng mL À1 were considered to be hyperprolactinaemic, between 16 ng mL À1 and 29 ng mL À1 moderately hyperprolactinaemic and #14 ng mL À1 normal. This project was approved by the National Zoo's Animal Care and Use Committee and by individual zoological facilities where elephants were housed.
Hormone analysis
Serum prolactin was measured by heterologous 125 I doubleantibody radioimmunoassay (RIA) as previously described (Brown and Lehnhardt 1997; Brown et al. 2004a) . All assays were conducted using a PBS-BSA buffer system (0.01 M PO 4 , 0.5% BSA, 2 mM EDTA, 0.9% NaCl and 0.01% thimerosal, pH 7.6), with the exception of the second antibody, where BSA was omitted. An anti-human prolactin antiserum (NIDDK-antihPRL-3) and ovine I 125 prolactin label and standards (NIDDKoPRL-I-2) were employed (both supplied by A. Parlow, NIDDK Hormone and Pituitary Program, Torrance, CA, USA). The assay was incubated at room temperature over a 3-day period. Assay sensitivity (based on 90% of maximum binding) was 1.0 ng mL À1 with intra-and inter-assay co-efficients of variation were ,10% and ,15%, respectively.
In contrast to most mammals, the major circulating luteal steroid in the elephant is not progesterone, but 5a-reduced pregnanes (Hodges et al. 1994 (Hodges et al. , 1997 . Serum was analysed using a solid-phase I 125 progesterone RIA (Seimens Medical Diagnostic Solutions, Costa Mesa, CA, USA) that has been validated for quantifying progestagens in elephant serum (Brown et al. 1991) . Sensitivity (based on 90% of maximum binding) was 0.03 ng mL À1 and intra-and inter-assay co-efficients of variation were ,10% and ,15%, respectively.
Data analysis
Statistical analyses were performed using SAS (SAS Institute Inc., Cary, NC, USA). PROC GLM of ANOVA for fixed-effects was used to determine overall differences in mean prolactin concentrations for a 1-year period between normal cycling, irregular cycling and acyclic elephants. Oestrous cycle length was based on serum progestagen concentration and calculated as the number of days from the first increase in serum progestagens until the next rise (Brown et al. 1999) . Prolactin peak and baseline concentrations were determined for each individual by an iterative process in which high values were excluded if they exceeded the mean plus two standard deviations (Brown et al. 1999) . The highest concentration within a group of elevated samples was considered to be a peak, and baseline values were those remaining after all high values had been excluded. For normal and irregular cycling females, overall mean prolactin concentration during the nonluteal and luteal phases of the oestrous cycle were averaged and compared. PROC MIXED of ANOVA for repeated-measures was used to determine differences in mean prolactin concentration between individual oestrous cycles within each individual for normal and irregular cycling elephants. In cases where the null hypothesis (no statistical differences between cyclicity groups) was rejected, Tukey-Kramer post hoc test was used to determine significant differences between groups. Correlation analysis was used to determine the relationship between prolactin and progestagens within normally cycling and irregular cycling females. Data are presented as mean AE s.e.m. Differences were considered to be significant at P , 0.05.
Results
Cycling elephants exhibited 4.2 AE 1.2 oestrous cycles over the 1-year study period (11 AE 0.4 weeks; range, 9-13 weeks). Irregular cycling elephants exhibited 2.4 AE 0.9 oestrous cycles over the same time period (18 AE 1.2 weeks; range 1-26 weeks). There was no clear progestagen pattern for irregular females; 30.7% (4 of 13) had prolonged nonluteal phases (22.1 AE 1.1 weeks; range, 18-26 weeks), 23.1% (3 of 13) had short nonluteal phases (1.9 AE 0.8 weeks; range, 1-3 weeks), 23.1% (3 of 13) had long luteal phases (12.3 AE 1.1 weeks; range, 12-14 weeks) and 23.1% (3 of 13) had short luteal phases (3.7 AE 0.9 weeks; range, 3-5 weeks). Serum prolactin data in normal cycling, irregular cycling and acyclic elephants are summarised in Table 1 . In both cycling groups, prolactin concentration was about three times higher during nonluteal phases as compared with the luteal phase (P , 0.05). Overall mean concentration throughout the oestrous cycle was not different between normal and irregular cycling females (P . 0.05). By contrast, acyclic females exhibited higher prolactin concentrations on average over the 1-year period than cycling elephants (P , 0.05), at levels that were similar to nonluteal-phase concentrations in cycling females. Prolactin data in acyclic females were further separated into 'high' (n ¼ 22 of 31; 71%) and 'low' (n ¼ 9; 29%) categories, with the concentration in the 'high' group being nearly 4 times greater than those during the oestrous cycle in cycling females (P , 0.05). By contrast, concentrations in the 'low' category were less than half of the overall oestrous cycle or 1-year means (P , 0.05), similar to those observed during the luteal phase of cycling individuals.
Figs 1-4 illustrate representative profiles of serum progestagens and prolactin in normal, irregular and noncycling female elephants, respectively. For normal cycling females, serum prolactin concentrations followed a recurring pattern, with concentrations being higher during the nonluteal phase (Fig. 1) . In general, prolactin started to increase as the progestagens were returning to baseline, peaked during the midpoint of the nonluteal phase, and then steadily declined to baseline as progestagens rose during the subsequent luteal phase. On average, prolactin concentration peaked at 29.27 AE 3.68 ng mL À1 and progestagens at around 0.60 AE 0.21 ng mL during their respective phases in the cycle. Prolactin secretion in the irregular cycling females generally followed a similar pattern with concentrations highest during periods of low progestagens (Fig. 2a) . In Fig. 2a , two successive waves of elevated prolactin of approximately equal duration were observed during a long nonluteal period that lasted 17 weeks. Between these two waves, prolactin was at baseline for ,4 weeks. Prolactin concentration was again low for ,5 weeks before a subsequent, normal-duration (9-week) luteal phase, but with relatively low overall progestagen concentration. In the next cycle, prolactin was increased throughout the following, extremely short (,1 week), nonluteal phase. In Fig. 2b , two successive waves of elevated prolactin were observed during a long nonluteal period that lasted at least 20 weeks; progestagens were at baseline concentration at the start of the monitoring period, and although monitoring began during the first wave of elevated prolactin, it appears that the overall mean concentration during this wave was higher than for subsequent waves. A total of three complete waves of elevated prolactin were observed in this individual, all of equal duration and overall mean concentration. During the long nonluteal phase at the beginning of sampling, a biphasic pattern of secretion was observed. After that, a normal 14-week cycle was observed, consisting of a 9-week luteal and 5-week nonluteal phase, followed by a comparatively long cycle ,24 weeks in duration; 13-week luteal and 11-week nonluteal phases. Again, prolactin was higher during nonluteal periods, but the increase started towards the end of the nonluteal phase in the middle cycle and right as progestagens were returning to baseline at the end of the luteal phase in the last cycle. In Fig. 2c , two luteal periods were observed during the monitoring period, with peak progestagen concentrations of 0.38 and 0.46 ng mL
À1
. Two successive waves of elevated prolactin of equal duration were observed during the long, 34-week nonluteal period between these two luteal phases. Overall mean prolactin concentration was higher in the first (20.83 AE 4.9 ng mL À1 ) compared with the second wave (10.62 AE 6.6 ng mL À1 ). Overall, for irregular cycling females, prolactin increased up to 2 weeks before to ,2 weeks after the start of a nonluteal phase. In addition, during periods of extended nonluteal phases where progestagens were maintained at baseline concentration, more than one biphasic elevation in prolactin was observed in 6 of 13 females (11 cycles). In Fig. 4 , both serum prolactin and progestagens were at low, baseline concentrations with no cyclic patterns observed in acyclic but not hyperprolactinaemic elephants. Serum prolactin and progestagen concentrations generally remained at or below 6.0 ng mL À1 and 0.10 ng mL À1 , respectively.
Discussion
Ovarian cycle problems in female African elephants have been well documented for over a decade, yet the aetiology remains unknown. This study examined one suspected cause of ovarian acyclicity in elephants, hyperprolactinaemia (Brown et al. 2004a) , and found that significant perturbations in circulating prolactin concentrations are observed only in acyclic females. Even more importantly, the proportion of females with hyperprolactinaemia appears to have significantly increased over the past 7 years (Brown et al. 2004a) . The females in this study represented 60% (31 of 51), 100% (31 of 31) and 100% (13 of 13) of the normal cycling, irregular cycling and acyclic female African elephants, respectively, recently identified in a recent Elephant Species Survival Plan (SSP) reproductive assessment survey (Dow et al. 2011) . Hyperprolactinaemia was observed in 71% of acyclic females in this study, but in only 37% (11 of 30) of noncycling elephants in 2004 (Brown et al. 2004a) . Perhaps related, rates of ovarian cycle problems have also increased over this period, from 22% in 2004 (Brown et al. 2004b ) to 41% in 2011 (Dow et al. 2011) . Of the 30 acyclic females from the 2004 study, five are deceased, nine are no longer monitored and 16 are still acyclic. Of the 16 acyclic females, four previously hyperprolactinaemic individuals are still hyperprolactinaemic and 14 of the 22 females previously with normal prolactin concentration are now hyperprolactinaemic (Brown et al. 2004a; Dow et al. 2011; T. Dow, unpubl. data) . In both endocrine studies, 100% of the acyclic elephants identified in SSP surveys were represented (Brown et al. 2004a ; present study), so there was not a selective bias towards hyperprolactinaemic elephants. Cause and effect has not been established because these two studies focussed on only two 1-year periods of time; however, the concomitant increase in ovarian problems and rates of hyperprolactinaemia is strongly suggestive of a physiological link between the two.
In women, hyperprolactinaemia is a known primary cause of infertility, and has a diverse pathophysiology (Yu et al. 1981; Jones 1989) . Prolactinomas account for 25-30% of functioning pituitary tumours and are a major contributor to hyperprolactinaemia (Webster and Scanlon 1997) . In some cases, tumour presence can physically block the secretion of gonadotrophins, thereby compromising oestrous cyclicity (Webster and Scanlon 1997) . There are numerous other conditions not associated with pituitary tumours that can result in high prolactin secretion, such as sleep disorders, tuberculosis, trauma and renal failure (Mah and Webster 2002) , although none are suspected to be a problem in our study animals based on veterinary records. A variety of pharmaceuticals have also been shown to either remove dopamine inhibition or directly stimulate prolactin secretion to cause an increase in prolactin secretion (La Torre and Falorni 2007) . These agents include neuroleptics (phenothiazines, haloperidol), antihypertensives (calcium-channel blockers, methyldopa), psychotropic drugs (tricyclic antidepressants) and anti-ulcer medications (H2 antagonists; La Torre and Falorni 2007) . Again, however, we have no evidence that any of the elephants in this study were exposed to prolactin-inducing chemical agents.
In addition to physiological and pharmacological effects, several endocrine factors have been identified as stimulants of prolactin synthesis: vasoactive intestinal polypeptide (VIP; Nicosia et al. 1983) , thyrotropin-releasing hormone (TRH; Tashjian et al. 1971 ) and oestradiol (Lieberman et al. 1978) . VIP in the brain is synthesised and secreted in two distinct areas, the hypothalamus and within lactotrophs in the anterior pituitary. One action of VIP is to stimulate prolactin mRNA synthesis by enhancing adenyl cyclase and subsequent cAMP directly at the lactotroph or indirectly through deactivation of the tuberoinfundibular dopamine system (Ajika et al. 1972; Meites et al. 1972; Ben-Jonathan et al. 2008) . Hypothalamic and lactotrophderived VIP has been shown to increase prolactin synthesis at the same time that dopamine is exerting an inhibitory effect (Ben-Jonathan et al. 2008) . It is possible that a secondary effect of acyclicity in elephants is a decrease in dopaminergic tone, resulting in elevated prolactin synthesis and suppression of hypothalamic GnRH. Neither dopamine nor VIP have been evaluated in African or Asian elephants, but given the obvious problem of hyperprolactinaemia-related problems in the African species, such investigations appear to be warranted.
Oestradiol is a known stimulator of prolactin secretion working both directly and indirectly at the anterior pituitary to increase prolactin synthesis and secretion (Lieberman et al. 1978) . Oestrogens act at the hypothalamus to decrease dopaminergic tone and on lactotroph cells to increase TRH receptors and block the dopamine-inhibiting decrease in cAMP at dopamine 2 receptors (Ben-Jonathan 1994) . TRH can increase prolactin production via direct stimulation by calcium or the subsequent phosphorylation of proteins through a calmodulin-dependent protein kinase (Tashjian et al. 1971) . A TRH challenge in a female African elephant resulted in an increase in serum prolactin concentrations (Bechert 1998) . However, in the 2004 study of Brown et al. (2004a) , serum oestradiol did not appear to be a contributing factor to hyperprolactinaemia in noncycling African elephants. Thus, because the stimulatory effect of TRH on lactotrophs is mediated through oestradiol, it is unlikely that TRH is a candidate for prolactin synthesis and secretion (Yamamoto et al. 2010; Prado-Oviedo 2011) . Finally, in women, obesity has been linked with amenorrhea and an increase in dopamine secretion (Doknic et al. 2002) , and there is some evidence that this may be the case for elephants. Captive African elephants are reported to be 27% heavier than their wild counterparts (Ange et al. 2001) , and a study by Freeman et al. (2009) found that ovarian acyclicity was associated with a higher body-mass index in zoo females. In addition, European zoos housing African elephants are experiencing similar problems (Clubb et al. 2009) . A study presently underway to correlate bodyweight and condition scores, subcutaneous fat deposits and serum nutritional biomarkers with ovarian-pituitary function may shed light on these putative relationships.
In African elephants, prolactin appears to participate in normal follicular development because concentrations increase during the nonluteal or follicular phase of the oestrous cycle and reach maximum levels immediately preceding ovulation (Bechert et al. 1999; Brown et al. 2004a) . In other species, prolactin regulates follicular development by altering gonadotrophin actions at both the hypothalamic-pituitary and ovarian levels, resulting in decreases in preantral and antral follicle numbers (Larsen et al. 1990) , cAMP levels and steroidogenic function (Gitay-Goren et al. 1989) and aromatase activity (Tsai-Morris et al. 1983) . Elephants are unique in that during the nonluteal phase they exhibit two quantitatively similar LH surges ,21 days apart, which correspond to two discrete follicular waves (Kapustin et al. 1996; Hermes et al. 2000; Lueders et al. 2010) ; only the second LH surge induces ovulation (Hodges 1998; Brown et al. 1999) . Prolactin has been shown to decrease plasminogen and metalloprotease concentrations within preovulatory follicles (Yoshimura et al. 1989 (Yoshimura et al. , 1990 (Yoshimura et al. , 1992 , both of which play pivotal roles in the degradation of tissue at the apex of an ovulatory follicle, facilitating follicle rupture and subsequent extrusion of the oocyte (Smith et al. 1999) . By decreasing enzymes involved in ovulation, increases in prolactin during the early nonluteal phase of the elephant cycle may function to prevent ovulation at the first LH surge. Prolactin then decreases immediately before ovulation (Brown et al. 2004a) , possibly resulting in an increase in plasminogen and metalloprotease activity that allows ovulation to occur. By contrast, the Asian elephant also exhibits two LH surges, but no cyclic pattern of prolactin secretion (Brown and Lehnhardt 1997 ). It may be significant then, that hyperprolactinaemia is only observed in African elephants; prolactin may not play a significant role in controlling ovarian function in the Asian species (Brown et al. 2004a) .
Increases in prolactin secretion during the nonluteal phase were observed in both normal and irregular cycling females. However, temporal patterns were more distinct in normal cycling elephants, with a stronger negative relationship existing between the two hormones (r ¼ À0.8) compared with irregular cycling females (r ¼ À0.6). Similar to progestagens, prolactin secretion patterns for the latter were, in fact, irregular. Unlike in normal cycling individuals where prolactin was elevated during the nonluteal phase until just before the ovulatory LH surge, in irregular cycling females increases in prolactin were observed anywhere from two weeks before to about two weeks after the start of the nonluteal phase, in some cases carrying over into the next luteal phase. In some irregular females experiencing prolonged nonluteal periods, more than one increase in prolactin was observed. This finding suggests that prolactin follows a somewhat regular pattern of secretion during periods of low progestagens, with each wave lasting ,8-10 weeks, similar to the single wave observed in normal cycling females.
While over two-thirds of acyclic female elephants exhibited hyperprolactinaemia in this study, we also observed acyclic female elephants with consistently low circulating serum prolactin concentrations and no cyclic temporal profiles. It is possible that in these females, a lack of oestradiol from growing follicles is responsible for reduced prolactin secretion. With no follicular development, oestrogens would not reach a threshold concentration to increase prolactin. Thus, low prolactin concentrations might be a consequence of acyclicity and not a contributing factor. However, if the problem is an increase in dopaminergic tone, constantly low prolactin secretion would result in the lack of a cyclical profile. As previously mentioned, in other species prolactin participates in a variety of regulatory mechanisms during the oestrous cycle, both stimulatory and inhibitory (Tsai-Morris et al. 1983; Gitay-Goren et al. 1989; Yoshimura et al. 1989 Yoshimura et al. , 1990 Yoshimura et al. , 1991 Yoshimura et al. , 1992 Zadworney et al. 1989; Larsen et al. 1990; Martel et al. 1990; Matsuyama et al. 1990; Smith et al. 1999) . Assuming that prolactin plays a stimulatory role in follicular development and ovulation in African elephants, its suppression could result in the types of ovarian dysfunction observed in females with low prolactin.
In summary, prolactin secretory patterns in acyclic verses normal and irregular cycling female African elephants are significantly altered. Although the exact mechanism of prolactin action in elephants is still unclear, it appears that perturbations in prolactin synthesis, either too much or too little, may be directly or indirectly involved in gonadal dysfunction. Most importantly, the frequency of hyperprolactinaemia appears to have increased dramatically and is now observed in 71% of acyclic females, up from 37% in 2004 (Brown et al. 2004a) . The next step is to determine if a loss in cyclical prolactin secretion during the nonluteal phase precedes acyclicity, acting as a causative factor, or if constant low prolactin synthesis is a consequence of the acyclic state. Given that our captive African elephant population is not self-sustaining, it is imperative to have all females of reproductive age cycling. One potential treatment option involves the use of cabergoline, a dopamine receptor agonist that has been shown to temporarily decrease circulating prolactin concentrations in hyperprolactinaemic elephants (Ball and Brown 2006) . A trial is now underway to determine if long-term cabergoline treatment (at least 1 year) will permit resumption of ovarian activity, similar to that observed in women (Dekkers et al. 2010) . By identifying causative factors of acyclicity, we hope to develop proper courses of treatment to mitigate ovarian cycle problems in reproductive-age female elephants, and prevent the population crash predicted for this species in zoos (Faust et al. 2006) .
